Severe hemorrhage causes significant hemodynamic instability, hypoxemia, multiple organ failure, and death. |
Perioperative hemostasis techniques include surgical ligatures, cautery, chemical agents, self-assembling nanoparticles, and topical methods. |
Topically-applied hemostatic agents include active agents, mechanical agents, synthetic agents, and external dressings. |
Topical mechanical agents only work in patients with intact coagulation system. |
Appropriate method is determined by the type of bleeding, the specific etiology, the individual coagulation status, and the clinician’s experience and preference. |
Future hemostatic agents can be engineered towards both primary and secondary hemostasis mechanisms for an enhanced hemostatic response. |
Introduction
Methods
Classifications of Topical Hemostatic Agents
Topical Active Hemostats
Fibrin-Based Active Adhesives
Fibrin Patch
Thrombin-Based Hemostats
Topical Combined Flowable Gelatin and Thrombin-Based Hemostats
Topical Mechanical Hemostats
Oxidized Cellulose
Gelatin-Based Mechanical Hemostats
Bovine Collagen Based Mechanical Hemostats
Polysaccharide-Based Mechanical Hemostats
Topical Synthetic Hemostatic Agents
Cyanoacrylates
Polyethylene Glycol Hydrogel
Glutaraldehyde Cross-Linked Albumin
Synthetic Topical Hemostatic Nanomolecules
External Hemostatic Dressings
Fibrinogen-Based Hemostatic Dressing
Zeolites-Based hemostatic dressing
Clay-Based Hemostatic Agents
Kaolin Group
Smectite Group
Polysaccharide and Polyelectrolyte
Category | Class | Mechanism(s) of action | Brand names | Clinical feature | |
---|---|---|---|---|---|
Topical active agent | Fibrin-based active adhesives and fibrin patch | Contains fibrinogen and/or thrombin, fibrin Trigger the coagulation cascade and fibrin clot formation actively Removal: metabolized by fibrinolysis and phagocytosis | Tiesseel, Evicel, Tachosil | Congenital or acquired bleeding disorders; coagulation disorders Not good for preventing pancreatic, biliary, urinary, and intestinal leakages | |
Thrombin-based topical hemostats | Thrombin JMI, Evithrom | ||||
Combined flowable gelatin and thrombin or collagen-based topical hemostats | Surgiflo, Floseal, Vitagel, Tachosil | ||||
Topical mechanical hemostats | Oxidized cellulose | Contain bovine collagen, oxidized cellulose, or gelatin, plant-derived polysaccharide spheres Provide a clotting matrix Promote platelet activation and aggregation Removal: absorbable by human body | Surgicel, Nu-Knit, Surgicel Fibrillar | Only indicated for patients with a functioning coagulation system Less effective in patient with thrombocytopenia; | |
Gelatin-based mechanical hemostats | Gelfilm, surgifoam,Gelfoam | ||||
Bovine collagen-based mechanical hemostats | Avitene, Avitene, Ultrafoam, UltraWrap, Instat, Helitene, Helistat | ||||
Polysaccharide-based mechanical hemostats | Arista, Hemostase, Vitasure | ||||
Topical synthetic/hemisynthetic hemostatic agents | Cyanoacrylates | Form a solid film polymerization to connect tissue surfaces | Dermabond | Dermabond for open wound bonding Butyl-2-cyanoacrylate for intravenous embolization; | |
Polyethylene glycol hydrogel | Sprayed on tissue to form a hydrogel matrix | CoSeal | Vascular anastomosis bleeding | ||
Glutaraldehyde cross-linked albumin | Chemical reaction between aldehydes and amines, provided by the ϵ-amino groups of lysine residues in albumin and extracellular matrix in the tissues | BioGlue | Tissue laceration or vascular graft bleeding | ||
Synthetic topical hemostatic nanomolecules | Self-assembling peptide or chitosan nanofibers facilitating coagulation | CaMXS | Especially suitable for bleeding in bone defect | ||
External hemostatic dressings | Fibrinogen-based hemostatic dressings | External mechanical pressure Increase local concentrations of platelets, clotting factors, and erythrocytes at the wound | Salmon thrombin-fibrinogen (STF) | Clot formation not hindered by hypothermia | |
Zeolites | Acts as a molecular sieve and rapidly adsorbs water Zeolite reaction with blood is exothermic | QuikClot, Advanced Clotting Sponge | Trauma-induced severe bleeding, removed from market in 2008 | ||
Clay-based hemostatic agents | Kaolin group | Kaolin activates factor XII Absorb water | QuikClot Combat Gauze, TraumaPad, | Traumatic open wound | |
Smectite group | WoundStat Celox Gauze (CEG) | WoundStat utilization was halted in 2009 | |||
Polysaccharide and Polyelectrolyte | 3rd generation chitosan-based dressings mechanically sealing wounds | HemCon | Trauma bleeding |